Canakinumab might be Protective against Severe COVID-19 for Patients with Autoinflammatory Disorders. | Mediterr J Rheumatol;33(2): 237-240, 2022 Jun. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

WHO COVID-19 Research Database

News/Update/Help

Advanced Search

The WHO Covid-19 Research Database is a resource created in response to the Public Health Emergency of International Concern (PHEIC). Its content remains searchable and spans the time period March 2020 to June 2023. Since June 2023, manual updates to the database have been discontinued.

Canakinumab might be Protective against Severe COVID-19 for Patients with Autoinflammatory Disorders.

Alkan, Arif; Ugurlu, Serdal.

Alkan A; Cerrahpasa Medical Faculty, University of Istanbul-Cerrahpasa, Istanbul, Turkey.
Ugurlu S; Division of Rheumatology, Department of Internal Medicine, Cerrahpasa Medical Faculty, University of Istanbul-Cerrahpasa, Istanbul, Turkey.

Mediterr J Rheumatol ; 33(2): 237-240, 2022 Jun.

Article in English | MEDLINE | ID: covidwho-2040652

Keywords

Autoinflammatory disease; Canakinumab; Covid-19; Familial Mediterranean Fever

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Language: English Journal: Mediterr J Rheumatol Year: 2022 Document Type: Article Affiliation country: Mjr.33.2.237

Similar

MEDLINE

LILACS

LIS

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Language: English Journal: Mediterr J Rheumatol Year: 2022 Document Type: Article Affiliation country: Mjr.33.2.237